August 10, 2023
As your Prescription Benefit Facilitator, BeneCard PBF is committed to providing the highest quality service, innovative clinical solutions, and valuable trend management strategies
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
July 10, 2023
The Food and Drug Administration granted traditional (full) approval to Leqembi, the Alzheimer’s
treatment jointly developed by Biogen and Eisai, on July 6th. In early June, external advisors to the FDA unanimously recommended Leqembi for full approval.
July 10, 2023
By Denise Mann HealthDay Reporter
July 10, 2023 - The drugs Wegovy and Ozempic are all the rage for weight loss these days, and now a new study shows these injections may be game-changers for obese teenagers, too.July 6, 2023
July 6, 2023 – Cipla Limited’s wholly-owned subsidiary Cipla US is voluntarily recalling six batches of
Albuterol
June 29, 2023
June 29, 2023 - BioMarin Pharmaceutical Inc., announced that the United States Food and Drug Administration (FDA) approved RoctavianTM
June 28, 2023
June 28, 2023 - Pfizer Inc. and OPKO Health Inc. announced that the U.S. Food and Drug Administration
(FDA) has approved Ngenla (somatrogon-ghla), a once-weekly
June 28, 2023
June 28, 2023 - The U.S. Food and Drug Administration approved Lantidra, the first allogeneic (donor)
pancreatic islet cellular therapy made from deceased donor pancreatic cells for the treatment
June 27, 2023
June 27, 2023 - UCB (Euronext Brussels: UCB), a global biopharmaceutical company, has announced Rystiggo (rozanolixizumab-noli) has been approved